Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

2,654

Participants

Timeline

Start Date

October 14, 2019

Primary Completion Date

October 29, 2020

Study Completion Date

December 13, 2020

Conditions
Influenza, Human
Interventions
BIOLOGICAL

NanoFlu

Investigational quadrivalent seasonal influenza vaccine for the 2019-20 Northern hemisphere influenza season.

BIOLOGICAL

Fluzone Quadrivalent

Licensed quadrivalent seasonal influenza vaccine for the 2019-20 Northern hemisphere influenza season.

Trial Locations (19)

13760

US017, Endwell

13901

US056, Binghamton

20854

US138, Rockville

29464

US079, Mt. Pleasant

30281

US013, Stockbridge

31406

US045, Savannah

33024

US135, Hollywood

37203

US029, Nashville

44122

US030, Cleveland

57049

US050, Dakota Dunes

66219

US003, Lenexa

68134

US018, Omaha

68701

US025, Norfolk

73112

US053, Oklahoma City

77375

US073, Tomball

78229

US004, San Antonio

83642

US012, Meridian

83687

US032, Nampa

02886

US044, Warwick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novavax

INDUSTRY